{"id":1493,"date":"2023-12-01T16:24:27","date_gmt":"2023-12-01T16:24:27","guid":{"rendered":"https:\/\/quantadt.com\/us\/?post_type=person&#038;p=1493"},"modified":"2023-12-04T14:55:16","modified_gmt":"2023-12-04T14:55:16","slug":"lloyd-mandel","status":"publish","type":"person","link":"https:\/\/quantadt.com\/us\/person\/lloyd-mandel\/","title":{"rendered":"Lloyd Mandell"},"content":{"rendered":"\n<p>Lloyd Mandell is a Managing Director and Head of Corporate Development at Glenview Capital.<\/p>\n\n\n\n<p>Mr. Mandell has more than 25 years of public and private market investment management experience with a focus on healthcare. At Glenview, he is a member of the Investment Committee and oversees private investments, currently serving as a board member at Identifeye, Limber Health and Quanta Dialysis Technologies. Mr. Mandell previously ran Coeus Capital and acted as a healthcare sector head or portfolio manager at several multi-billion-dollar funds including Davidson Kempner, Carlson Capital and Roystone Capital.<\/p>\n\n\n\n<p>Mr. Mandell is a dual degree Summa Cum Laude graduate of the Jerome Fisher Program in Management &amp; Technology at the University of Pennsylvania.<\/p>\n","protected":false},"featured_media":1494,"template":"","meta":{"_acf_changed":false,"content-type":""},"class_list":["post-1493","person","type-person","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/person\/1493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/person"}],"about":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/types\/person"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/media\/1494"}],"wp:attachment":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/media?parent=1493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}